[HTML][HTML] Erlotinib in previously treated non–small-cell lung cancer
FA Shepherd, J Rodrigues Pereira… - New England journal …, 2005 - Mass Medical Soc
Background We conducted a randomized, placebo-controlled, double-blind trial to
determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival …
determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival …
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd, JR Pereira… - The New England …, 2005 - pubmed.ncbi.nlm.nih.gov
Background We conducted a randomized, placebo-controlled, double-blind trial to
determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival …
determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival …
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd, JR Pereira, T Ciuleanu, HT Eng, V Hirsh… - 2005 - cmuir.cmu.ac.th
BACKGROUND: We conducted a randomized, placebo-controlled, double-blind trial to
determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival …
determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival …
[引用][C] Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd, JR Pereira, T Ciuleanu, HT Eng, V Hirsh… - 2005 - cmudc.library.cmu.ac.th
Chiang Mai University Digital Collections CMUDC Logo หน้าแรก คอลเล็กชัน สถิติเจ้าของผลงาน
ช่วยเหลือ คู่มือการเข้าสู่ระบบ เกี่ยวกับ เข้าสู่ระบบ th en book Erlotinib in previously treated non-small-cell …
ช่วยเหลือ คู่มือการเข้าสู่ระบบ เกี่ยวกับ เข้าสู่ระบบ th en book Erlotinib in previously treated non-small-cell …
[PDF][PDF] Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
FA Shepherd, JR Pereira, T Ciuleanu, EH Tan… - N Engl J Med, 2005 - academia.edu
Patients with stage IIIB or IV non–small-cell lung cancer, with performance status from 0 to 3,
were eligible if they had received one or two prior chemotherapy regimens. The patients …
were eligible if they had received one or two prior chemotherapy regimens. The patients …
Erlotinib in previously treated non-small-cell lung cancer.
FA Shepherd, T Ciuleanu, EH Tan, V Hirsh… - The New England …, 2005 - europepmc.org
Background We conducted a randomized, placebo-controlled, double-blind trial to
determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival …
determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival …
[引用][C] Erlotinib in previously treated non-small-cell lung cancer
F SHEPHERD - N Engl J Med, 2005 - cir.nii.ac.jp
[引用][C] Erlotinib in previously treated non-small-cell lung cancer
FA SHEPHERD, JR PEREIRA… - The New England …, 2005 - pascal-francis.inist.fr
Erlotinib in previously treated non-small-cell lung cancer CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
[PDF][PDF] Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
FA Shepherd, JR Pereira, T Ciuleanu… - N Engl J …, 2005 - mauriciolema.webhost4life.com
Patients with stage IIIB or IV non–small-cell lung cancer, with performance status from 0 to 3,
were eligible if they had received one or two prior chemotherapy regimens. The patients …
were eligible if they had received one or two prior chemotherapy regimens. The patients …
[PDF][PDF] Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
FA Shepherd, JR Pereira, T Ciuleanu, EH Tan… - N Engl J …, 2005 - osvepharma.com
Patients with stage IIIB or IV non–small-cell lung cancer, with performance status from 0 to 3,
were eligible if they had received one or two prior chemotherapy regimens. The patients …
were eligible if they had received one or two prior chemotherapy regimens. The patients …